Boston Scientific Q3 Adj. EPS $0.50 Beats $0.48 Estimate, Sales $3.53B Beat $3.47B Estimate
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific reported Q3 earnings of $0.50 per share, beating the analyst consensus estimate of $0.48 by 4.17%. This is a 16.28% increase from the same period last year. The company also reported quarterly sales of $3.53 billion, beating the analyst consensus estimate of $3.47 billion by 1.64%, a 11.26% increase from the same period last year.
October 26, 2023 | 10:38 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific's Q3 earnings and sales beat analyst estimates, showing a significant YoY increase.
Boston Scientific's Q3 earnings and sales exceeded analyst estimates, indicating strong financial performance. This is likely to boost investor confidence and could lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100